Lv1
34 积分 2023-09-27 加入
E3 ubiquitin ligase RNF180 reduces sensitivity of triple-negative breast cancer cells to Gefitinib by downregulating RAD51
1天前
已完结
Fatal Spitz Melanoma With MAD1L1::BRAF Fusion: A Case Report and Literature Review
16天前
已完结
Fusion Gene Detection in Driver Mutation‐Negative Melanomas Using RNA ‐Based Anchored Multiplex Polymerase Chain Reaction
16天前
已完结
Comparative Analysis of Somatic and Germline Polymerase Proofreading Deficiencies in Cancer: Molecular and Clinical Implications
1个月前
已完结
Rare EGFR E709-T710delinsX: Molecular characteristics and superior response to afatinib treatment in NSCLC patients
1个月前
已完结
Ipatasertib plus abiraterone and prednisolone in metastatic castration-resistant prostate cancer (IPATential150): a multicentre, randomised, double-blind, phase 3 trial
1个月前
已完结
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
1个月前
已完结
A phase I/IB trial of binimetinib in combination with erlotinib in NSCLC harboring activating KRAS or EGFR mutations
1个月前
已完结
A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer
1个月前
已完结
MET Fusions in NSCLC: Clinicopathologic Features and Response to MET Inhibition
1个月前
已完结
皖公网安备34019202002308
